“The challenges being addressed by CASMI are central to our ability to meet the demands of improving visual health, especially in the elderly. To be able to bring together the expertise of Oxford and UCL is a remarkable opportunity.”
Phil Luthert is Director of the UCL Institute of Ophthalmology and Professor of Pathology. He trained in medicine at St George’s Hospital Medical School in London in clinical medicine, followed by a move to the Department of Neuropathology at the Institute of Psychiatry. Initial studies there addressed the pathophysiology of the blood-brain barrier, particularly in experimental tumour models. Interests then shifted to neuropathology of neurodegenerative disease including movement disorders, dementia and then the impact of HIV infection on the nervous system.
In 1994 he moved to the Pathology Department at the UCL Institute of Ophthalmology and spent a short time at the Wilmer Eye Institute, Johns Hopkins University, training in ophthalmic pathology. Wide-ranging research interests since then include the pathogenesis of inherited retinal degeneration and novel approaches to photoreceptor rescue and more recently, the cellular basis of age-related macular degeneration. He is currently interested in informatics and healthcare.